Time New York: Tue 18 Sep 10:05 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Pacific Biosciences (PACB) Jumps: Stock Rises 5.4%

Zacks

Pacific Biosciences of California, Inc. PACB was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.11 to $4.99 in the past one-month time frame.

The company has not seen any estimate revisions over the past month and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Pacific Biosciences currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

Pacific Biosciences of California, Inc. Price

Pacific Biosciences of California, Inc. Price | Pacific Biosciences of California, Inc. Quote


A better-ranked stock in the Medical – Instruments industry is Intuitive Surgical, Inc. ISRG, which currently has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PACB going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.